Jacob M. Chacko holds the position of Chairman at Bright Peak Therapeutics AG, Chairman for Bright Peak Therapeutics, Inc. and President, Chief Executive Officer & Director at Oric Pharmaceuticals, Inc.

He is also on the board of Arog Pharmaceuticals, Inc. and 4D Molecular Therapeutics, Inc.

In his past career he was Chief Financial Officer at Ignyta, Inc. and Vice President for TPG Capital LP.

He received a doctorate from the University of California, Los Angeles, a graduate degree from the University of Oxford, an undergraduate degree from the University of Southern California and an MBA from Harvard Business School.